Miach Orthopaedics, Inc., today announced the presentation of one- and two-year results of the Bridge Registry study at the recent American Orthopaedic Society for Sports Medicine (AOSSM) annual meeting.
Miach Orthopaedics is continuing to collect data on the implant through post-market and label expansion studies – BEAR III and BEAR-MOON – as well as the Bridge Registry study. Understanding how the ACL works and how to facilitate its healing has come a long way in the last 30 years.
About Miach Orthopaedics, Inc. Miach Orthopaedics, Inc., is a privately held company located in Westborough, Massachusetts, dedicated to developing bio-engineered surgical implants for connective tissue restoration.
About Miach Orthopaedics, Inc. Miach Orthopaedics, Inc., is a privately held company located in Westborough, Massachusetts, dedicated to developing surgical implants to facilitate connective tissue restoration. The company’s initial focus is the BEAR ® Implant, which represents a paradigm shift in the treatment of ACL tears.
Our History The BEAR Implant was pioneered by Martha Murray, MD, founder of Miach Orthopaedics, at the Boston Children’s Hospital Department of Orthopaedic Surgery, with initial research funding provided by the NFL Players Association, Boston Children’s Hospital and the National Institutes of Health.
Address 69 Milk St. Westborough, MA 01581 © Miach Orthopaedics | All Rights Reserved.
The Major League Soccer Players Association (MLSPA), SV Health Investors and Aperture Venture Partners Join Existing Investors to Support Commercial Expansion and Clinical Activities for BEAR® Implant WESTBOROUGH, Massachusetts – – Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with ...
WESTBOROUGH, Mass.--(BUSINESS WIRE)--Miach Orthopaedics, Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue restoration, today announced the ...